Impact of Virtual Reality in Hematology and Oncology During Invasive Procedures in Children, Adolescents and Young Adults, from 7 to Less Than 25 Years Old

Launched by POITIERS UNIVERSITY HOSPITAL · Mar 10, 2022

Keywords

ClinConnect Summary

This clinical trial is exploring the use of virtual reality (VR) to help children with cancer manage pain and anxiety during medical procedures. It focuses on kids aged 7 to under 18 who need certain treatments, like a lumbar puncture (a procedure to collect spinal fluid) or accessing an implantable port for chemotherapy. The study will compare how well using VR works for reducing pain and stress versus standard methods like nitrous oxide (a gas used for pain relief) and medications.

To be eligible for the trial, children must be able to understand French, have parental or guardian consent, and can be participating in treatment for blood or cancer-related issues. However, children with certain conditions or emergencies, or those who have difficulty using a VR headset, won't be included. If they participate, children can expect to be randomly assigned to either the VR group or the usual treatment group and will have support throughout the process. This study aims to see if VR can provide the same benefits as traditional pain relief methods in a fun and engaging way.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients aged 7 to strictly under 25
• • Follow-ups for hematological or oncological pathology
• • With a lumbar puncture or to connection to an implantable chamber
• • Patient understanding French
• • Consent of parents or guardians with parental authority.
• • Child informed and having given his assent
• Exclusion Criteria:
• • Children with cognitive impairment
• • Children in absolute emergency situations
• • Children with a contraindication to a virtual reality headset (psychiatric pathology, vestibular and proprioceptive disorders, unbalanced epilepsy, impaired vision, hearing aids, claustrophobia, recent lesions of the eyes, face or scalp)
• • Children who have already participated in the clinical investigation
• • Refusal to participate in the study
• • Patients not benefiting from a social security system or not benefiting from it by the intermediary of a third person